Get the App

Back Stocks profile

Stock analysis tool for investors

Sotac Pharmaceuticals Ltd

NSE: SOTAC | BSE:

₹130.10 13.55 (11.63%) 1D

Pharmaceuticals & Biotechnology

Buy Sell

Open an Account with Bigul in 5 minutes

Performance

Today’s low

113.00

Today’s High

132.00

52W low

97.00

52W High

155.00

Open Price

115.00

Prev. Close

122.1000

Volume

14400.00

Value

1873440.00

Fundamentals

Market Cap Cr

143.80

Price to Earnings

39.10

Price to Book Value

14.10

Dividend Yield

0.00

PE to Growth

0.00

Op Revenue TTM Cr

95.47

Net Profit TTM Cr

3.67

Cash From Operating Activity Cr

8.14

Return on Equity %

22.88

EMA & SMA

Bullish Moving Averages

13

Bearish Moving Averages

1

5Day EMA

122.4

10Day EMA

124

12Day EMA

124.5

20Day EMA

125.9

26Day EMA

126.5

50Day EMA

126.9

100Day EMA

125.7

EMA

5Day SMA

123.7

10Day SMA

124.4

20Day SMA

125.4

30Day SMA

131

50Day SMA

127.8

100Day SMA

124.9

150Day SMA

124

SMA

DELIVERY AND VOLUME

DAILY AVG. DELIVERY VOLUME %

16 May, 2024

100

Week

93.3

Month

LEGEND

Positive Indicator

Neutral Indicator

Negative Indicator

RESISTANCE AND SUPPORT

117.85

PIVOT

First Resistance

120.70

Second Resistance

124.85

Third Resistance

127.70

First Support

113.70

Second Support

110.85

Third Support

106.70

Relative Strength Index

38.22

Money Flow Index

30.12

MACD

-2.02

MACD Signal

-1.42

Average True Range

4.79

Average Directional Index

13.99

Rate of Change (21)

-7.5

Rate of Change (125)

0.47

Commodity Channel Index

-186.1

Williams %R

-90.9

BETA

1 Month

0.55

3 Month

1.47

1 Year

3 Year

PRICE CHANGE ANALYSIS

↑ 3.25%

1 Week

Low

High

113

132

↑ 6.64%

1 Month

Low

High

113

132

↑ 6.64%

3 Months

Low

High

113

155

↑ 5.82%

6 Months

Low

High

111.15

155

↓ -7.24%

1 Year

Low

High

97

155

Indicator Dec 2023 Sep 2023 Jun 2023 Mar 2023 Sep 2022 Jun 2022 Graph
Total Qtr Revenue cr 17.95 14.49 19.14 13.30 15.75 15.11
Operating Expenses Qtr 14.75 11.51 16.65 10.80 13.56 12.12
Operating Profit Qtr 2.93 2.69 2.26 2.38 2.14 2.93
EBIDT Qtr Cr 2.97 2.98 2.49 2.51 2.19 2.99
Depreciation Qtr 0.68 0.63 0.46 0.45 0.40 0.34
Net Profit Qtr 1.49 1.67 1.21 1.23 1.24 1.86
Basic EPS Qtr 2.65 1.51 1.12 1.53 5.37 8.07
Indicator Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Total Revenue Annual 58.23 73.37 43.52 28.76
Operating Expenses Annual Cr 49.77 67.02 40.64 26.54
Operating Profit Annual 8.21 6.14 2.80 2.07
Operating Profit Margin Annual % 14.10 8.36 6.44 7.19
Total Expenses Annual Cr 52.26 68.68 42.31 27.85
EBIDT Annual Cr 8.45 6.35 2.88 2.22
EBIDT Annual margin % 14.51 8.66 6.62 7.73
Depreciation 1.63 1.13 1.12 1.07
PAT Before ExtraOrdinary Items Annual Cr 4.50 2.88 0.86 0.71
Net Profit Annual 4.50 2.88 0.86 0.71
Basic EPS Annual 5.58 12.51 3.75 7.13
Indicator Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Total ShareHolders Funds Annual 11.52 6.62 4.22 3.37
Minority Interest Liability Annual Cr - - - -
Total Non Current Liabilities Annual Cr 6.68 1.03 2.77 3.20
Total Current Liabilities Annual Cr 27.11 27.61 14.91 14.64
Total Capital Plus Liabilities Annual Cr 54.78 35.25 21.91 21.21
Fixed Assets Annual 14.13 8.80 6.42 6.41
Total Non Current Assets Annual 18.18 9.38 8.75 8.61
Total Current Assets Annual 36.61 25.88 13.15 12.60
Total Assets Annual 54.78 35.25 21.91 21.21
Contingent Liabilities plus Commitments Annual Cr 0.00 0.40 0.00 0.00
Indicator Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Cash from Operating Activity Annual 8.54 6.35 2.35 -0.25
Cash from Investing Activity Annual -10.93 -3.52 -1.20 -1.84
Cash from Financing Annual Activity 11.97 -2.83 -1.17 1.75
Net Cash Flow Annual 9.57 0.00 -0.02 -0.34
Indicator Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Book Value Per Share Annual 14.31 28.79 18.35 14.67
ROE Annual % 39.02 43.47 20.43 20.93
ROCE Annual % 24.66 68.34 25.20 17.57
Total Debt to Total Equity Annual 0.93 1.12 1.58 2.13
EBDIT Annual Margin % 14.57 8.68 6.63 7.77
Indicator Dec 2023 Sep 2023 Jun 2023 Mar 2023 Sep 2022 Jun 2022 Graph
Total Qtr Revenue cr 26.35 26.51 25.20 18.22 20.01 19.94
Operating Expenses Qtr 22.83 24.59 22.63 15.67 18.39 17.95
Operating Profit Qtr 2.92 2.09 2.34 2.42 1.48 1.92
EBIDT Qtr Cr 3.29 1.92 2.57 2.55 2.20 1.99
Depreciation Qtr 0.83 0.78 0.60 0.61 0.61 0.50
Net Profit Qtr 0.90 0.75 0.98 1.04 1.02 0.54
Basic EPS Qtr 0.82 0.19 0.92 1.29 2.08 2.33
Indicator Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Total Revenue Annual 77.83 73.37 48.95 28.83
Operating Expenses Annual Cr 70.23 67.02 47.39 26.74
Operating Profit Annual 7.25 6.14 1.45 1.86
Operating Profit Margin Annual % 9.32 8.36 2.97 6.46
Total Expenses Annual Cr 74.49 68.68 51.01 28.47
EBIDT Annual Cr 7.60 6.35 1.56 2.08
EBIDT Annual margin % 9.76 8.66 3.19 7.23
Depreciation 2.28 1.13 2.59 1.40
PAT Before ExtraOrdinary Items Annual Cr 2.29 2.88 -2.37 0.09
Net Profit Annual 2.29 2.88 -2.37 0.09
Basic EPS Annual 2.84 12.51 -10.28 0.89
Indicator Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Total ShareHolders Funds Annual 9.99 6.62 2.49 3.06
Minority Interest Liability Annual Cr 0.23 0.00 0.07 1.66
Total Non Current Liabilities Annual Cr 8.14 1.03 9.37 6.33
Total Current Liabilities Annual Cr 45.81 27.61 22.76 19.34
Total Capital Plus Liabilities Annual Cr 73.64 35.25 34.70 30.38
Fixed Assets Annual 24.05 8.80 16.56 15.99
Total Non Current Assets Annual 26.50 9.38 17.35 16.63
Total Current Assets Annual 47.14 25.88 17.35 13.75
Total Assets Annual 73.64 35.25 34.70 30.38
Contingent Liabilities plus Commitments Annual Cr 0.00 0.40 0.00 0.00
Indicator Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Cash from Operating Activity Annual 8.14 6.35 -0.31 0.06
Cash from Investing Activity Annual -11.67 -3.52 -3.23 -11.75
Cash from Financing Annual Activity 13.14 -2.83 3.38 11.40
Net Cash Flow Annual 9.61 0.00 -0.16 -0.29
Indicator Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Book Value Per Share Annual 12.69 28.79 11.16 20.49
ROE Annual % 22.88 43.47 -94.85 2.86
ROCE Annual % 19.12 68.34 -8.64 6.20
Total Debt to Total Equity Annual 2.21 1.12 6.87 4.40
EBDIT Annual Margin % 9.80 8.68 3.19 7.28
Name Holding Percent Holding Id Pledged % Locked %
Name Holding Percent Holding Id Pledged % Locked %
Kiran Baldevbhai Jotania 13.11 74533899 0 100
Dineshkumar Babulal Gelot 12.95 74533897 0 100
Sharadkumar Dashrathbhai Patel 12.95 74533898 0 100
Vishalkumar Devrajbhai Patel 12.95 74533900 0 100
Chetankumar Bachubhai Patel 9.68 74533896 0 100
Shaileshkumar Vishnuprasad Patel 7.29 74533904 0 100
Mitul Shaileshkumar Patel 3.28 74533906 0 100
Name Holding Percent Holding Id
NAV CAPITAL VCC - NAV CAPITAL EMERGING STAR FUND 7.3 74533909
MINERVA VENTURES FUND 1.64 74533910
Name Holding Percent Holding Id
HUF 0.6 74533920
GOENKA BUSINESS AND FINANCE LIMITED 3.96 74533916
SAMBHAVNATH INVESTMENTS AND FINANCES PRIVATE LIMIT 3.18 74533918
WALPAR NUTRITIONS LIMITED 1.49 74533917
Ex-Date Dividend Amount Dividend Type Record Date Instrument Type
Ex-Date Split Ratio Record Date
Ex-Date Purpose Notes
Nov 06, 2023 Quarterly Results -
May 29, 2023 Audited Results -
Ex-Date Bonus Ratio Record Date

FAQs

The latest market price of Sotac Pharmaceuticals Ltd on NSE was Rs. 130.10 as of today.

The opening share price of Sotac Pharmaceuticals Ltd was Rs. 115.00 as of today.

The 52-week high share price of Sotac Pharmaceuticals Ltd was Rs. 155.00.

The 52 week low share price of Sotac Pharmaceuticals Ltd was Rs. 97.00.

Sotac Pharmaceuticals Ltd has a market cap of Rs. 143.80 crore as of today. Please refer to the Fundamentals section for further details.

The PE ratio of Sotac Pharmaceuticals Ltd is 0.00. Please refer to the Fundamentals section for further details.

The operating revenue for Sotac Pharmaceuticals Ltd in the last FY was Rs.  95.47 crore. Please refer to the Financials section for further details.

The Net Profit for Sotac Pharmaceuticals Ltd in the last FY was Rs. 3.67 crore. Please refer to the Financials section for further details.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

Please find Corporate actions section for more details.

Please find Corporate actions section for more details.

Please find Corporate actions section for more details.

Please refer to Bigul Traders Corner, One Stop destination for different algo and non-algo trading strategies and tools meant for investors, traders, and strategists. Our qualified experts with rich experience in broking, financial analysis, and software development designed it in-house. Click here to learn more.

Please refer to JARVIS, which is Bigul’s AI Portfolio Manager Tool that uses artificial intelligence algorithms to make investment decisions in a portfolio. Click here to learn more.

Please refer to the News section for the latest news about Sotac Pharmaceuticals Ltd.

Close

Let's Open Free Demat Account